Adekunle Ojatula | PhytoMedicine | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Adekunle Ojatula | PhytoMedicine | Best Researcher Award

Olusegun Agagu University of Science and Technology | Nigeria

Dr. Adekunle Orimisan Ojatula is a distinguished Nigerian academic and researcher specializing in Phytomedicine with expertise in herbal medicine, ethnobotany, and natural product research. He is currently an Assistant Professor in the Department of Biological Sciences at Olusegun Agagu University of Science and Technology, Okitipupa. Dr. Ojatula’s scholarly journey is rooted in his passion for the therapeutic applications of medicinal plants and the integration of indigenous knowledge with modern drug discovery approaches. His research spans ethnomedicinal surveys, phytochemistry, biomolecular characterization, safety assessments of herbal preparations, and the standardization of herbal drugs for global health sustainability. He has contributed significantly to curriculum innovation in herbal sciences and remains dedicated to bridging traditional medicine with contemporary biomedical research. Beyond academia, he consults for herbal clinics, delivers public lectures, and mentors postgraduate students, making impactful contributions to healthcare, education, and national development through his academic excellence and professional service.

Profile

Google scholar

Education

Dr. Adekunle Ojatula pursued his academic training across prestigious Nigerian institutions, building a strong foundation in plant sciences and herbal medicine. He earned his Bachelor of Science degree in Botany from Ambrose Alli University, Ekpoma, where he graduated with distinction as the best student in his class. Driven by his interest in phytomedicine, he proceeded to the University of Benin, where he obtained his Master of Science in Phytomedicine, focusing on the phytochemical evaluation of medicinal plants with aphrodisiac properties. He further advanced his studies at the same university, where he completed his Ph.D. in Phytomedicine with a dissertation on the bioactivity and safety assessment of Pausinystalia yohimbe root extract, demonstrating its pharmacological and reproductive health significance. His academic path reflects a consistent dedication to herbal medicine research, emphasizing the interplay between indigenous knowledge systems and modern biomedical applications. This solid educational background underpins his expertise as a teacher, researcher, and consultant.

Experience

Dr. Adekunle Ojatula’s professional career demonstrates a steady rise through academia, research, and consultancy. At Olusegun Agagu University of Science and Technology, he has served in diverse roles, from Lecturer II to Senior Lecturer, contributing to teaching, curriculum design, and departmental leadership. He has coordinated seminars, supervised postgraduate students, and provided academic guidance in the Botany program. His administrative contributions include coordinating SIWES, unit headship in Botany, and course advisement, ensuring quality student development. Beyond the university, he has engaged in herbal clinical training and consultancy, offering evidence-based approaches to traditional medicine at clinics such as Pax Herbal and Eureka Herbal Clinic. His involvement in professional societies broadens his collaborative reach, while his public lectures and national-level academic proposals showcase his commitment to advancing herbal sciences in Nigeria. Dr. Ojatula’s multifaceted experience highlights his academic rigor, leadership, and passion for integrating research with societal and health impacts.

Awards and Honors

Dr. Adekunle Ojatula’s academic brilliance and professional contributions have been recognized through notable awards and honors. During his undergraduate studies, he received the Distinction Merit Award as the Best Graduating Student in Botany, a testament to his dedication and intellectual excellence. He has also been honored by student bodies, such as the Botany Graduating Students of Olusegun Agagu University of Science and Technology, who recognized his mentorship and academic impact with an Award of Honour. In addition, he has been acknowledged for his outstanding service to the academic community through Certificates of Excellence in Reviewing, reflecting his critical role in ensuring quality scholarly publications. His achievements extend beyond accolades, as he has also attracted competitive research grants, most notably from TETFund, supporting groundbreaking studies on herbal plants for reproductive health. These distinctions not only validate his individual excellence but also highlight his broader contribution to advancing knowledge in herbal medicine.

Research Focus

Dr. Adekunle Ojatula’s research focus is firmly centered on phytomedicine, with particular emphasis on drug discovery, formulation, and development from natural plant sources. He integrates ethnobotanical knowledge with modern scientific methods to validate the therapeutic applications of herbal plants, ensuring their safety, efficacy, and standardization. His work involves phytochemical screening, biomolecular characterization, bioactivity studies, and toxicity assessments of medicinal plants, especially those with reproductive and cardiovascular health benefits. A strong advocate of indigenous knowledge systems, he documents and investigates the ethnomedicinal practices of communities, contributing to both cultural preservation and biomedical advancement. His analytical expertise extends to microscopic studies and herbal drug formulation, bridging traditional practices with global pharmaceutical standards. By addressing issues of quality, safety, and efficacy in herbal medicine, his research contributes to modernizing the field while supporting national healthcare systems. His studies have wide-reaching implications for natural drug innovation, health sustainability, and economic development.

 

Publications

 

Title: Aphrodisiac potentials of Pausinystalia yohimbe (K. Schum.) Pierre ex Beille methanol root extract in male Wistar rats
Year: 2020
Citation: 11

Title: Ethnomedicinal survey of plants used in the treatment of male sexual dysfunction among the Ilaje people of Ondo State, Nigeria
Year: 2015
Citation: 11

Title: Developmental botanic: A case study on chromatographic determination of phytocompounds in the roots of Anthocleista nobilis (G. Don.) as pro-fertility
Year: 2021
Citation: 10

Title: Spermatogenic efficacy of Pausinystalia yohimbe (K. Schum.) Pierre ex Beille roots in male rats
Year: 2020
Citation: 10

Title: Preliminary Assessment of Acute and 14–Days Repeated Dose Oral Toxicity of Pausinystalia yohimbe (K. Schum.) Pierre ex Beille Methanol Root Extract on Experimental Rats
Year: 2020
Citation: 7

Title: Biomolecules and Phytominerals Profiling of Pausinystalia yohimbe (K. Schum.) Pierre ex Beille Root Extract
Year: 2019
Citation: 6

Title: Effects of Pausinystalia yohimbe Methanol Root Extract on Some Cardiovascular and Haematological Variables in Wistar Rats
Year: 2019
Citation: 6

Title: In-vitro Studies on the Herbal Plant Microdesmis keayana Methanol Leaves Extract Phytocomponents by GC-MS Analysis: A Further Evidence for its Phytomedicinal Potentials
Year: 2023
Citation: 5

Conclusion

Dr. Adekunle Orimisan Ojatula is a visionary scholar in phytomedicine whose contributions in herbal drug discovery, ethnomedicine, and academic innovation continue to bridge indigenous knowledge with global biomedical science, making him an outstanding figure in research, teaching, and professional service.

Rohit Pal | Pharmaceutical Chemistry | Young Scientist Award

Published on by Cognitive Scientist Awards

Mr. Rohit Pal | Pharmaceutical Chemistry | Young Scientist Award

PhD Scholar at Acharya and BM Reddy College of Pharmacy, Bengaluru, India

Mr. Rohit Pal is a dedicated and emerging researcher in the field of pharmaceutical sciences, particularly focusing on drug discovery and development. Currently pursuing his Ph.D. at Acharya & BM Reddy College of Pharmacy in Bengaluru, he is engaged in innovative research on Pyrimidine derivatives as fourth-generation EGFR inhibitors to combat Non-Small Cell Lung Cancer (NSCLC). With a strong academic background, including an M.Pharmacy in Pharmaceutical Chemistry, Mr. Pal combines his expertise in chemical synthesis with cutting-edge computational techniques like molecular docking and structure-activity relationship (SAR) analysis. His work spans multiple research areas, including anticonvulsant activity, anti-inflammatory research, and the pharmacognostic standardization of endangered species like Passiflora vitifolia. Throughout his career, Mr. Pal has demonstrated a capacity for both in-silico drug design and experimental testing, balancing theoretical approaches with hands-on experimentation. His impressive publication record in respected journals further showcases his capability to contribute to the scientific community. As a promising young researcher, Mr. Pal’s ongoing work not only advances pharmaceutical sciences but also holds potential for meaningful clinical applications in cancer therapy and drug design.

Profile

Orcid

 

Education 🎓

Mr. Rohit Pal’s educational background demonstrates a consistent pursuit of excellence in the field of pharmaceutical sciences. He is currently enrolled in a Ph.D. program at Acharya & BM Reddy College of Pharmacy in Bengaluru, Karnataka, where his research is focused on the development of Pyrimidine derivatives as EGFR inhibitors to target Non-Small Cell Lung Cancer (NSCLC). Prior to his doctoral studies, Mr. Pal completed his M.Pharmacy in Pharmaceutical Chemistry from ISF College of Pharmacy in Moga, Punjab, achieving a notable CGPA of 9.07. His academic journey began with a B. Pharmacy from Dev Bhoomi Institute of Pharmacy and Research, Dehradun, where he gained a robust foundation in pharmaceutical sciences. Additionally, Mr. Pal holds a D. Pharmacy from SGGS College of Pharmacy, Chandigarh, further demonstrating his dedication to the field from the onset of his academic career. His varied educational experiences have shaped his interdisciplinary approach to pharmaceutical research, combining knowledge from chemistry, biology, and computational sciences. This solid academic foundation has propelled Mr. Pal to explore complex drug development challenges, particularly in cancer therapy, with a keen interest in molecular-level drug interactions.

Work Experience 💼

Mr. Rohit Pal’s professional experience reflects a promising trajectory in pharmaceutical research and drug discovery. As a Ph.D. scholar at Acharya & BM Reddy College of Pharmacy, he is deeply involved in researching Pyrimidine derivatives for EGFR inhibition in Non-Small Cell Lung Cancer (NSCLC). His research explores the design, synthesis, and evaluation of novel drug candidates, combining in-vitro testing with computational drug design. Through the use of molecular docking and structure-activity relationship (SAR) analysis, Mr. Pal aims to identify compounds with high therapeutic potential. Beyond his Ph.D. work, Mr. Pal has worked on various other research projects, including 1,2,4-triazine derivatives for anticonvulsant activity and the anti-inflammatory properties of Passiflora vitifolia, an endangered plant species. His work spans both synthetic chemistry and biological testing, allowing him to gain expertise in pharmacological assays and computational modeling. Mr. Pal’s professional experience also includes using sophisticated instruments such as HPLC, UV spectrophotometers, and Microwave Synthesizers, which complement his experimental work and ensure the reliability of his results. These experiences have positioned him well for future leadership roles in pharmaceutical research and drug developmen

Awards and Honors

Although still in the early stages of his academic career, Mr. Rohit Pal has already garnered significant recognition for his research efforts. His academic excellence is reflected in his M.Pharmacy CGPA of 9.07, placing him among the top students in his cohort. Mr. Pal’s research has been published in reputable journals such as the Journal of Biomolecular Structure and Dynamics and Chemical Physics Impact, demonstrating the impact and quality of his work. These publications are indicative of his ability to produce research that contributes to the scientific community. Despite being early in his career, his involvement in cutting-edge research on Pyrimidine derivatives and EGFR inhibitors has already gained attention within the academic and pharmaceutical fields. His dedication to molecular docking, drug design, and pharmacognostic studies positions him for further recognition. As Mr. Pal continues to contribute to innovative drug development solutions, he is likely to receive more prestigious awards and honors, reflecting the growing importance of his work in cancer research and pharmaceutical chemistry.

Research Interests

Mr. Rohit Pal’s research interests are centered around the intersection of pharmaceutical chemistry and drug discovery. His primary focus is on developing Pyrimidine derivatives as fourth-generation EGFR inhibitors aimed at Non-Small Cell Lung Cancer (NSCLC), a serious health concern with limited therapeutic options. By targeting the epidermal growth factor receptor (EGFR), his work could offer more effective treatment alternatives for cancer patients. In addition to cancer research, Mr. Pal has explored 1,2,4-triazine derivatives for evaluating anticonvulsant activity, contributing to neurological disorder treatments. He is also interested in anti-inflammatory research, with a particular focus on Passiflora vitifolia, an endangered plant species, aiming to standardize its pharmacognostic properties. His multidisciplinary approach extends to the application of computational drug design, where he utilizes molecular docking and molecular dynamics simulations to predict drug-receptor interactions. Mr. Pal is committed to advancing drug development by combining experimental chemistry with in-silico methodologies, offering innovative solutions for complex healthcare challenges. His work on drug repurposing, targeted therapies, and sustainable drug sourcing reflects his holistic approach to addressing both scientific and global health concerns.

Research Skills

Mr. Rohit Pal possesses a wide range of research skills essential for successful pharmaceutical research. His proficiency in chemical synthesis includes techniques such as recrystallization, sublimation, and flash chromatography, which he applies to purify and isolate new compounds for testing. In addition to these laboratory techniques, Mr. Pal is highly skilled in analytical methods, including HPLC and UV spectrophotometry, to assess the purity and chemical composition of compounds. He is also adept at utilizing computational tools for drug design, particularly AutoDock, Biovia Drug Discovery Studio, and Pymol, to perform molecular docking and molecular dynamics simulations. These tools allow him to predict the interactions between drug candidates and their targets, enhancing the efficiency of drug development. Furthermore, Mr. Pal has experience in in-vitro biological testing, including assays for anticonvulsant, anti-inflammatory, and antioxidant activities, ensuring the biological relevance of his synthesized compounds. His ability to combine experimental techniques with computational modeling equips him to approach drug discovery from both theoretical and practical angles, ensuring well-rounded and impactful research outcomes.

📚 Publications

  • Design, synthesis, and biological evaluation of novel 4-(4-ethoxyphenyl)-6-(substituted-phenyl)pyrimidin-2-amine/thiol/hydroxy derivatives as EGFRWT and EGFRT790M inhibitors targeting NSCLC: In-vitro and in-silico exploration
    • Journal: Journal of Molecular Structure
    • DOI: 10.1016/j.molstruc.2024.141227
    • Date: April 2025
    • Contributors: Rohit Pal; Gurubasavaraja Swamy Purawarga Matada; Ghanshyam Teli; Viney Chawla; Pooja A. Chawla
  • Next-generation cancer therapeutics: PROTACs and the role of heterocyclic warheads in targeting resistance
    • Journal: European Journal of Medicinal Chemistry
    • DOI: 10.1016/j.ejmech.2024.117034
    • Date: January 2025
    • Contributors: Ebna Azizal Omar; Rajesh R.; Pronoy Kanti Das; Rohit Pal; Gurubasavaraja Swamy Purawarga Matada; Lalmohan Maji
  • Benzothiazole a privileged scaffold for cutting-edge anticancer agents: Exploring drug design, structure-activity relationship, and docking studies
    • Journal: European Journal of Medicinal Chemistry
    • DOI: 10.1016/j.ejmech.2024.116831
    • Date: December 2024
    • Contributors: Aayishamma I; Gurubasavaraja Swamy Purawarga Matada; Rohit Pal; Abhishek Ghara; Nimmagadda Venkata Satya Sai Aishwarya; Kumaraswamy B; Ketan R. Hosamani; Manjushree B V; Haripriya E
  • An outlook of docking analysis and structure-activity relationship of pyrimidine-based analogues as EGFR inhibitors against non-small cell lung cancer (NSCLC)
    • Journal: Journal of Biomolecular Structure and Dynamics
    • DOI: 10.1080/07391102.2023.2252082
    • Date: December 11, 2024
    • Contributors: Rohit Pal; Ghanshyam Teli; Sindhuja Sengupta; Lalmohan Maji; Gurubasavaraja Swamy Purawarga Matada
  • Exploring the anticancer potential of triazine derivatives: An outlook of designing strategies, docking studies, and structure-activity relationships (SAR)
    • Journal: ChemistrySelect
    • DOI: 10.1002/slct.202402766
    • Date: November 2024
    • Contributors: B. V. Manjushree; Gurubasavaraja Swamy Purawarga Matada; Rohit Pal; Md. Ashadul Sk; M. P. Viji; Nimmagadda Venkata Satya Sai Aishwarya; Pronoy Kanti Das; I. Aayishamma; S. Mounika
  • Pyrazole, pyrazoline, and fused pyrazole derivatives: New horizons in EGFR-targeted anticancer agents
    • Journal: Chemistry & Biodiversity
    • DOI: 10.1002/cbdv.202400880
    • Date: November 2024
    • Contributors: Ketan R Hosamani; Hemalatha K; Rohit Pal; Gurubasavaraja Swamy Purawarga Matada; Kumaraswamy B; Aayishamma I; Nimmagadda Venkata Satya Sai Aishwarya

Conclusion 

Mr. Rohit Pal is an exceptionally talented and promising researcher in the field of pharmaceutical sciences. His research, focused on Pyrimidine derivatives as EGFR inhibitors for Non-Small Cell Lung Cancer (NSCLC), is not only innovative but holds significant promise for advancing cancer treatment. His combination of chemical synthesis, computational drug design, and biological testing reflects his multidisciplinary approach to pharmaceutical research. Mr. Pal’s commitment to anti-inflammatory, anticonvulsant, and pharmacognostic standardization further demonstrates his versatility as a researcher. While still in the early stages of his career, his publication record and expertise in molecular docking and drug design suggest that he is well on his way to becoming a leader in pharmaceutical research. His ongoing work could contribute to groundbreaking advancements in cancer therapy, neurological disorder treatments, and sustainable drug sourcing. With his strong educational background, solid professional experience, and growing body of work, Mr. Rohit Pal is undoubtedly a candidate with the potential to make meaningful contributions to drug development and global health. His future in research looks bright, and he is well-positioned for recognition in upcoming awards such as the Young Scientist Award.